Document:

c50495_ex10-22.htm -- Converted by SEC Publisher, created by BCL Technologies Inc., for SEC Filing

NEITHER THIS DEBENTURE NOR THE SECURITIES INTO WHICH THIS DEBENTURE IS CONVERTIBLE HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”) OR ANY STATE SECURITIES LAWS AND NEITHER THIS DEBENTURE NOR
ANY INTEREST THEREIN NOR THE SECURITIES INTO WHICH THIS DEBENTURE IS CONVERTIBLE MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT AND SUCH LAWS OR AN EXEMPTION
FROM REGISTRATION UNDER SUCH ACT AND SUCH LAWS WHICH, IN THE OPINION OF COUNSEL SATISFACTORY TO THE COMPANY, IS AVAILABLE. 

ASSURED PHARMACY, INC. 

18% Unsecured Convertible Debenture 

	
$
		
, 2007
	

This Unsecured Convertible Debenture (the “Debenture”)
is issued by Assured Pharmacy, Inc., a Nevada Corporation (the “Company”)
this __ day of ________, 200_ (the “Issuance Date”) to ____________________
having an address at _________________ pursuant to exemptions from registration
under the Securities Act of 1933, as amended. 

ARTICLE I.

PRINCIPAL AND INTEREST

Section 1.1. For value received, the Company promises to pay
to Holder, or its registered assigns, the principal sum of $______, on or
before ___________, 200_ (the “Maturity Date”), and to pay
interest to the Holder on the principal amount of this Debenture (the “Principal
Amount”) at the rate of 18.0% per annum, with interest for the period from
the Issuance Date to the Maturity Date payable in full on the Issuance Date.
All  interest due under this Debenture shall be paid by the Company solely in
shares of the Company’s Common Stock. The number of shares of Common Stock
to be issued in payment of the interest due under this Debenture shall be calculated
based upon  the average closing price for the Company’s common stock on
the NASD OTCBB for the five (5) consecutive trading days preceding the Issuance
Date and the total number of shares of Common Stock to be issued as interest
is _______. All
payments of principal and interest shall be made to the Holder at the address set forth above or such other address as the Holder shall notify the Company in writing ten (10) days prior to the due date of any payment or upon any prepayment of this
Debenture as provided herein. 

Section 1.2. Unsecured Nature of Debenture. This Debenture is unsecured. 

ARTICLE II.

CONVERSION RIGHTS; CONVERSION PRICE

Section 2.1. Voluntary Conversion by Holder. The Holder shall have the right prior to the date on which this Debenture is paid in full, to convert at any time, or from time to time, any part of the outstanding Principal Amount of
this Debenture into fully paid and non-assessable shares of Common Stock and Common Stock Purchase Warrants (“Conversion Warrants”) of the Company (the “Conversion Units”) at the Conversion Price (as defined below) determined as
provided herein. Promptly after the surrender of this Debenture, accompanied by a Notice of Conversion of Convertible Debenture in the form attached hereto as Exhibit 1, properly completed and duly executed by the Holder (a “Conversion
Notice”), the Company shall issue and deliver to or upon the order of the Holder that number of shares of Common Stock and Conversion Warrants in the form attached hereto as Exhibit 2 and Exhibit 3 for the balance of this Debenture converted as
shall be determined in accordance herewith. The Conversion Warrants evidenced by Exhibit 2 to be issued following receipt of the Conversion Notice are exercisable for shares of the Company’s Common Stock at an exercise price of $0.60 per
share for a period of one year (the “$0.60 Warrants”). The Conversion Warrants evidenced by Exhibit 3 to be issued following receipt of the Conversion Notice are exercisable for shares of the Company’s Common Stock at an exercise
price of $0.80 per share for a period of two years (the “$0.80 Warrants”). 

Section 2.2. The number of shares of Common Stock to be issued upon each conversion of this Debenture shall be determined by dividing (i) the amount of Principal to be converted by (ii) the Conversion Price. The number of
Conversion Warrants to be issued to Holder upon conversion of this Debenture shall be equal to the number of shares of Common Stock issued upon conversion of this Debenture, with such number of Conversion Warrants to be divided equally between
$0.60 Warrants and $0.80 Warrants. 

Section 2.3. Conversion Price. Upon any conversion of this Debenture, the conversion price shall be $0.40, subject to adjustment from time to time upon the happening of certain events (the “Conversion Price”) as set
forth below. 

(a) Stock Splits, etc. In case the Company shall: (i) pay a dividend in shares of Common Stock or make a distribution in shares of Common Stock to holders of its
outstanding Common Stock, (ii) subdivide its outstanding shares of Common Stock into a greater number of shares of Common Stock, (iii) combine its outstanding shares of Common Stock into a smaller number of shares of Common Stock, or (iv) issue any
shares of its capital stock in a reclassification of the Common Stock, then the number of Conversion Units issuable upon conversion of this Debenture immediately prior thereto shall be adjusted so that the holder of this Debenture shall be entitled
to receive the kind 

and number of Conversion Units which he would have owned or have been entitled to receive had such Debenture been converted in advance thereof. Upon each such adjustment of the kind and number of Conversion Units the holder of
this Debenture shall thereafter be entitled to purchase the number of Conversion Units resulting from such adjustment at a Conversion Price per Conversion Unit obtained by multiplying the Conversion Price in effect immediately prior to such
adjustment by the number of Conversion Units issuable pursuant hereto immediately prior to such adjustment and dividing by the number of Conversion Units of the Company resulting from such adjustment. An adjustment made pursuant to this paragraph
shall become effective immediately after the effective date of such event retroactive to the record date, if any, for such event. 

(b) Reorganization, Reclassification, Merger, Consolidation or Disposition of Assets. In case the Company shall reorganize its capital, reclassify its capital stock,
consolidate or merge with or into another corporation (where the Company is not the surviving corporation or where there is a change in or distribution with respect to the Common Stock of the Company), or sell, transfer or otherwise dispose of all
or substantially all its property, assets or business to another corporation and, pursuant to the terms of such reorganization, reclassification, merger, consolidation or disposition of assets, shares of common stock of the successor or acquiring
corporation, or any cash, shares of stock or other securities or property of any nature whatsoever (including warrants or other subscription or purchase rights) in addition to or in lieu of common stock of the successor or acquiring corporation
(“Other Property”), are to be received by or distributed to the holders of Common Stock of the Company, then Holder shall have the right thereafter to receive, upon conversion of this Debenture, Conversion Units for the number of shares of
common stock, and warrants to purchase common stock, of the successor or acquiring corporation or of the Company, if it is the surviving corporation, and Other Property receivable upon or as a result of such reorganization, reclassification, merger,
consolidation or disposition of assets by a holder of the number of Conversion Units into which this Debenture is convertible immediately prior to such event. In case of any such reorganization, reclassification, merger, consolidation or disposition
of assets, the successor or acquiring corporation (if other than the Company) shall expressly assume the due and punctual observance and performance of each and every covenant and condition of this Debenture to be performed and observed by the
Company and all the obligations and liabilities hereunder, subject to such modifications as may be deemed appropriate (as determined in good faith by resolution of the Board of Directors of the Company) in order to provide for adjustments of
Conversion Units into which this Debenture is convertible which shall be as nearly equivalent as practicable to the adjustments provided for in this Section 2.3(b). For purposes of this Section 2.3(b), “common stock of the successor or
acquiring corporation” shall include stock of such corporation of any class which is not preferred as to dividends or assets over any other class of stock of such corporation and which is not subject to redemption and shall also include any
evidences of indebtedness, shares of stock or other securities which are convertible into or exchangeable for any such stock, either immediately or upon the arrival of a specified date or the happening of a specified event and any warrants or other

rights to subscribe for or purchase any such stock. The foregoing provisions of this Section 2.3(b) shall similarly apply to successive reorganizations, reclassifications, mergers, consolidations or disposition of assets.

(c) Notice of Adjustment. Whenever the number of Conversion Units or number or kind of securities or other property issuable upon the conversion of this Debenture or the
Conversion Price is adjusted, as herein provided, the Company shall promptly mail by registered or certified mail, return receipt requested, to the holder of this Debenture notice of such adjustment or adjustments setting forth the number of
Conversion Units (and other securities or property) issuable upon the conversion of this Debenture and the Conversion Price of such Conversion Units (and other securities or property) after such adjustment, setting forth a brief statement of the
facts requiring such adjustment and setting forth the computation by which such adjustment was made. Such notice, in the absence of manifest error, shall be conclusive evidence of the correctness of such adjustment. 

Section 2.4. Notice of Corporate Action. If at any time:

(a) the Company shall take a record of the holders of its Common Stock for the purpose of entitling them to receive a dividend or other distribution, or any right to subscribe for or purchase any evidences of its indebtedness, any
shares of stock of any class or any other securities or property, or to receive any other right, or 

(b) there shall be any capital reorganization of the Company, any reclassification or recapitalization of the capital stock of the Company or any consolidation or merger of the Company with, or any sale, transfer or other
disposition of all or substantially all the property, assets or business of the Company to, another corporation or, 

(c) there shall be a voluntary or involuntary dissolution, liquidation or winding up of the Company; 

then, in any one or more of such cases, the Company shall give to Holder (i) at least 30 days’ prior written notice of the date on which a record date shall be selected for such dividend, distribution or right or for
determining rights to vote in respect of any such reorganization, reclassification, merger, consolidation, sale, transfer, disposition, liquidation or winding up, and (ii) in the case of any such reorganization, reclassification, merger,
consolidation, sale, transfer, disposition, dissolution, liquidation or winding up, at least 30 days’ prior written notice of the date when the same shall take place. Such notice in accordance with the foregoing clause also shall specify (x)
the date on which any such record is to be taken for the purpose of such dividend, distribution or right, the date on which the holders of Common Stock shall be entitled to any such dividend, 

distribution or right, and the amount and character thereof, and (y) the date on which any such reorganization, reclassification, merger, consolidation, sale, transfer, disposition, dissolution, liquidation or winding up is to
take place and the time, if any such time is to be fixed, as of which the holders of Common Stock shall be entitled to exchange their shares of Common Stock for securities or other property deliverable upon such disposition, dissolution, liquidation
or winding up. Each such written notice shall be sufficiently given if addressed to Holder at the last address of Holder appearing on the books of the Company and delivered in accordance with Section 5.1. 

Section 2.5. Method of Conversion. Except as otherwise provided in this Debenture or agreed to by the Holder, this Debenture may be converted by the Holder pursuant to its conversion rights set forth in Section 2.1 in whole at any
time or in part (provided each such partial conversion is at least $10,000) by submitting to the Company a Conversion Notice (by facsimile dispatched on the Conversion Date and confirmed by U.S. mail or overnight mail service sent within two
business days thereafter) and surrendering this Debenture with the mailed confirmation of the Conversion Notice at the office of the Company as provided in Section 5.1. Upon a partial conversion of this Debenture, a new debenture containing the same
date and provisions as this Debenture shall be issued by the Company to the Holder for the balance due hereunder which shall not have been converted. 

Section 2.6. Restrictions on Securities. This Debenture has been issued by the Company pursuant to the exemption from registration under the Securities Act of 1933, as amended (the “Act”). None of this Debenture, the
shares of Common Stock and Conversion Warrants issuable upon conversion of this Debenture, or the shares of Common Stock of the Company issuable upon exercise of the Conversion Warrants (the “Warrant Shares”) may be offered, sold or
otherwise transferred unless (i) they first shall have been registered under the Act and applicable state securities laws or (ii) the Company shall have been furnished with an opinion of legal counsel (in form, substance and scope reasonably
acceptable to Company) to the effect that such sale or transfer is exempt from the registration requirements of the Act. Each certificate for shares of Common Stock and Conversion Warrants issuable upon conversion of this Debenture and Warrant
Shares issuable upon exercise of the Conversion Warrants that have not been so registered and that have not been sold pursuant to an exemption that permits removal of the applicable legend, shall bear a legend substantially in the following form, as
appropriate: 

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 (THE “ACT”). THE SECURITIES REPRESENTED HEREBY MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED UNLESS THEY ARE REGISTERED
UNDER THE ACT AND APPLICABLE STATE 

SECURITIES LAWS, OR SUCH OFFERS, SALES AND TRANSFERS ARE MADE PURSUANT TO AN AVAILABLE EXEMPTION FROM THE REGISTRATION REQUIREMENTS OF THOSE LAWS. 

Upon the request of a holder of a certificate representing any shares of Common Stock issuable upon conversion of this Debenture, the Company shall remove the foregoing legend from the certificate or issue to such Holder a new
certificate free of any transfer legend, if (a) with such request, the Company shall have received an opinion of counsel, reasonably satisfactory to the Company in form, substance and scope, to the effect that any such legend may be removed from
such certificate or (b) a registration statement under the Act covering such securities is in effect. 

Section 2.7. Registration Rights. If at any time the Company proposes to register any of its common stock under the Act, whether as a result of an offering for its own account or the account of others, excluding any registrations
to be effected on Forms S-4 or S-8 or other applicable successor Forms, the Company shall, at such time, promptly give Holder written notice of such proposed registration and offer Holder the opportunity to include the shares of common stock issued
as interest, the shares of Common Stock issuable upon conversion of this Debenture and the Warrant Shares issuable upon exercise of the Conversion Warrants in such registration statement (each, a “Piggy Back Registration”). The Company
shall include in any such registration statement all or part of the underlying common stock that Holder requests to be registered. In a Piggyback Registration, the Company will pay the registration expenses and the reasonable fees. 

Section 2.8. Reservation of Common Stock.

(a) The Company covenants that during the period the Debenture is outstanding, it will reserve from its authorized and unissued Common Stock a sufficient number of shares to provide for the issuance of Common Stock of the Company
upon the Conversion of the Debenture. The Company further covenants that its issuance of this Debenture shall constitute full authority to its officers who are charged with the duty of executing stock certificates and warrants to execute and issue
the necessary certificates for shares of Common Stock of the Company, and the Conversion Warrants, issuable upon the conversion of this Debenture. The Company will take all such reasonable action as may be necessary to assure that such Conversion
Units may be issued as provided herein without violation of any applicable law or regulation, or of any requirements of the NASD OTCBB (or such other principal market upon which the Common Stock of the Company may be listed). 

(b) The Company shall not by any action, including, without limitation, amending its certificate of incorporation or through any reorganization, transfer of assets, consolidation, merger, dissolution, issue or sale of securities
or any other voluntary action, with the purpose to avoid or seek to avoid the observance or performance of any

of the terms of this Debenture, but will at all times in good faith assist in the carrying out of all such terms and in the taking of all such actions as may be necessary or appropriate to protect the rights of Holder against
impairment. Without limiting the generality of the foregoing, the Company will (a) not increase the par value of any shares of Common Stock issuable upon the conversion of this Debenture above the amount payable therefor upon such conversion
immediately prior to such increase in par value, (b) take all such action as may be necessary or appropriate in order that the Company may validly and legally issue fully paid and nonassessable shares of Common Stock and Conversion Warrants upon the
conversion of this Debenture, and (c) use its best efforts to obtain all such authorizations, exemptions or consents from any public regulatory body having jurisdiction thereof as may be necessary to enable the Company to perform its obligations
under this Debenture. 

(c) Upon the request of Holder, the Company will at any time during the period this Debenture is outstanding acknowledge in writing the continuing validity of this Debenture and the obligations of the Company hereunder. 

(d) Before taking any action which would cause an adjustment reducing the current Conversion Price below the then par value, if any, of the shares of Common Stock issuable upon conversion of the Debentures, the Company shall take
any corporate action which may be necessary in order that the Company may validly and legally issue fully paid and non-assessable shares of such Common Stock at such adjusted Conversion Price. 

(e) Before taking any action which would result in an adjustment in the number of Conversion Units into which this Debenture is convertible or in the Conversion Price, the Company shall obtain all such authorizations or exemptions
thereof, or consents thereto, as may be necessary from any public regulatory body or bodies having jurisdiction thereof. 

(f) If at any time the Company does not have a sufficient number of authorized and available shares of Common Stock for issuance upon conversion of the Debenture, then the Company shall call and hold a special meeting of its
stockholders within forty-five (45) days of that time for the sole purpose of increasing the number of authorized shares of Common Stock. 

Section 2.9. Prepayment.

(a) The Company shall have the option to prepay some or all of the outstanding Principal Amount of this Debenture, pursuant to the provisions of this Section 2.9. The prepayment price shall be equal to the
outstanding Principal Amount (or portion thereof) to be prepaid as of the date of prepayment (the “Prepayment Date”). If this Debenture is called for prepayment pursuant this Section 2.9, the Company shall give written notice to the Holder
not less than thirty (30) days nor more than sixty (60) days prior to the Prepayment Date, setting forth the prepayment price to be paid, instructions 

for presentation of the Debentures for prepayment and the Prepayment Date. Upon notice of any prepayment, the Company covenants and agrees that upon presentation of the Debentures, it will pay on the Prepayment Date the Principal
to be prepaid as specified in such notice (the “Prepayment Amount”). Holders may convert their Debentures pursuant to Article II of this Debenture during the period from the date of notice of prepayment until 5:00 p.m. Eastern Time on the
business day immediately prior to the Prepayment Date. 

(b) If all of the outstanding Principal Amount of this Debenture is being prepaid, and if the Holder does not wish to convert the Debenture, the Holder should cause such Debenture to be timely delivered to the Company at its
principal offices after receiving the notice of prepayment required by this Section 2.9. 

(c) If (i) upon notice of any prepayment a Holder determines not to convert his debenture with in the period provided in Section 2.9(a); and (ii) on or before the Prepayment Date the Company makes payment to Holder of 100% of the
outstanding Principal Amount of the Debenture, then, on and after said Prepayment Date, notwithstanding that this Debenture shall not have been surrendered for prepayment, the obligation evidenced by the Debenture shall be deemed no longer
outstanding, and all rights with respect thereto shall forthwith cease and terminate. 

Section 2.10. Paying Agent and Registrar. Initially, the Company will act as paying agent and registrar. The Company may change any paying agent, registrar, or Company registrar by giving the Holder not less than ten (10) business
days’ written notice of its election to do so, specifying the name, address, telephone number and facsimile number of the paying agent or registrar. 

Section 2.11. Anything in this Debenture to the contrary notwithstanding, in no event shall there be any adjustment to the interest due under this Debenture or the total number of shares of Common Stock of the Company issued as
interest hereunder, including, without limitation, upon, in connection with or as a result of any conversion or prepayment of this Debenture; and, (ii) in no event shall Holder be obligated to return, refund, rebate or transfer any such interest or
shares of Common Stock of the Company issued as interest hereunder including, without limitation, upon, in connection with or as a result of any conversion or prepayment of this Debenture. 

ARTICLE III.

REPRESENTATIONS AND WARRANTIES OF HOLDER

Section 3.1. The Holder represents and warrants to the Company: 

(a) The Holder of this Debenture, by acceptance hereof, agrees that this Debenture

is being acquired for investment and that such Holder will not offer, sell or otherwise dispose of this Debenture or the Common Stock or Conversion Warrants issuable upon conversion hereof or Warrant Shares issuable upon exercise
of the Conversion Warrants except under circumstances that will not result in a violation of the Act or any application state securities laws or similar laws relating to the sale of securities; 

(b) That Holder understands that none of this Debenture or the Common Stock or Conversion Warrants issuable upon conversion hereof or Warrant Shares issuable upon exercise of the Conversion Warrants have been registered under the
Securities Act of 1933, as amended (the “Act”), in reliance upon the exemptions from the registration provisions of the Act and any continued reliance on such exemption is predicated on the representations of the Holder set forth herein;

(c) Holder (i) has adequate means of providing for his current needs and possible contingencies, (ii) has no need for liquidity in this investment, (iii) is able to bear the substantial economic risks of an investment in this
Debenture for an indefinite period, (iv) at the present time, can afford a complete loss of such investment, and (v) does not have an overall commitment to investments which are not readily marketable that is disproportionate to Holder’s net
worth, and Holder’s investment in this Debenture will not cause such overall commitment to become excessive; 

(d) Holder is an “accredited investor” (as defined in Regulation D promulgated under the Act) and the Holder’s total investment in this Debenture does not exceed 10% of the Holder’s net worth; and 

(e) Holder recognizes that an investment in the Company involves significant risks and only investors who can afford the loss of their entire investment should consider investing in the Company and this Debenture. 

ARTICLE IV.

EVENTS OF DEFAULT

Section 4.1 Default. In case one or more of the following events (“Events of Default”) (whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or be effected by operation of law or
pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body) shall have occurred and be continuing: 

(a) default in the due and punctual payment of all or any part of the Principal Amount as and when such amount or such part thereof shall become due and payable hereunder; or 

(b) failure on the part of the Company duly to observe or perform in all material respects any of the covenants or agreements on the part of the Company contained herein (other than those covered by clause (a) above) for a period
of 10 business days after the 

date on which written notice specifying such failure, stating that such notice is a “Notice of Default” hereunder and demanding that the Company remedy the same, shall have been given by the Holder by registered or
certified mail, return receipt requested, to the Company; or 

(c) any of the following actions by the Company pursuant to or within the meaning title 11, U.S. Code or any similar federal or state law for the relief of debtors (collectively, the “Bankruptcy Law”): (A) commencement
of a voluntary case or proceeding, (B) consent to the entry of an order for relief against it in an involuntary case or proceeding, (C) consents to the appointment of a receiver, trustee, assignee, liquidator or similar official under any Bankruptcy
Law (each, a “Custodian”), of it or for all or substantially all of its property, (D) a general assignment for the benefit of its creditors, or (E) admission in writing its inability to pay its debts as the same become due; or 

(d) entry by a court of competent jurisdiction of an order or decree under any Bankruptcy Law that: (A) is for relief against the Company in an involuntary case, (B) appoints a Custodian of the Company or for all or substantially
all of the property of the Company, or (C) orders the liquidation of the Company, and such order or decree remains unstayed and in effect for 60 days; 

then, in each case where an Event of Default specified in Section 4.1(b) occurs, the Holder, by notice in writing to the Company (the “Acceleration Notice”), may declare the outstanding Principal Amount (in whole or in
part) to be due and payable immediately, and upon any such declaration the same shall become immediately due and payable; provided, however, that if an Event of Default specified in Section 4.1(a), (c) or (d) occurs, the outstanding Principal Amount
shall become and be immediately due and payable without any declaration or other act on the part of the Holder. 

Section 4.2. Payment of Costs. The Company shall reimburse the Holder, on demand, for any and all reasonable costs and expenses, including reasonable attorneys’ fees and disbursement and court costs, incurred by the Holder in
collecting or otherwise enforcing this Note or in attempting to collect or enforce this Note. 

Section 4.3. Powers and Remedies Cumulative; Delay or Omission Not Waiver of Default. No right or remedy herein conferred upon or reserved to the Holder is intended to be exclusive of any other right or remedy available to Holder
under applicable law, and every such right and remedy shall, to the extent permitted by law, be cumulative and in addition to every other right and remedy given hereunder or now or hereafter existing at law or in equity or otherwise. The assertion
or employment of any right or remedy hereunder, or otherwise, shall not prevent the concurrent assertion or employment of any other appropriate right or remedy. No delay or omission of the Holder to exercise any right or power accruing upon any
Default occurring and continuing as aforesaid shall impair any such right or power or shall be construed to be a waiver of any such Default or an acquiescence therein; and every power and remedy given by this Note or by law may be exercised from
time to time, and as often as shall be deemed expedient, by the Holder. Section 4.4. Waiver of Past Defaults. The Holder may waive any past default or Event 

of Default hereunder and its consequences but no such waiver shall extend to any subsequent or other default or Event of Default or impair any right consequent thereon. Section 4.5. Waiver of Presentment etc. The Company hereby
waives presentment, demand, notice, protest and all other demands and notices in connection with the delivery, acceptance, performance and enforcement of this Debenture, except as specifically provided herein. 

ARTICLE V. 

MISCELLANEOUS

Section 5.1. Notices. Any notice herein required or permitted to be given shall be in writing and may be personally served or delivered by courier or sent by United States mail and shall be deemed to have been given upon receipt
if personally served (which shall include telephone line facsimile transmission) or sent by courier or three (3) days after being deposited in the United States mail, certified, with postage pre-paid and properly addressed, if sent by mail. For the
purposes hereof, the address of the Holder shall be as shown on the records of the Company; and the address of the Company shall be 17935 Sky Park Circle, Suite F, Irvine, California 92614. Both the Holder and the Company may change the address for
service by delivery of written notice to the other as herein provided. 

Section 5.2. Entire Agreement and Amendment Provision. This Debenture represents the entire agreement between the parties hereto with respect to the subject matter hereof and there are no representations, warranties or
commitments, except as set forth herein. This Debenture and any provision hereof may be amended only by an instrument in writing signed by the Company and the Holder. 

Section 5.3. Assignability. This Debenture shall be binding upon the Company and its successors and assigns and shall inure to be the benefit of the Holder and its successors and assigns; provided, however, that so long as no
Event of Default has occurred, this Debenture shall only be transferable in whole subject to the restrictions contained in the restrictive legend on the first page of this Debenture. 

Section 5.4. Governing Law. This Debenture shall be governed by the internal laws of the State of Nevada, without regard to conflicts of laws principles. The parties hereto hereby submit to the exclusive jurisdiction and venue of
the state or federal courts sited in Clark County, Nevada with respect to any dispute arising under this Debenture. 

Section 5.5. Replacement of Debenture. The Company covenants that upon receipt by the Company of evidence reasonably satisfactory to it of the loss, theft, destruction or mutilation of this Debenture, and in case of loss, theft or
destruction, of indemnity or security reasonably satisfactory to it (which may not include the posting of any bond), and upon surrender and cancellation of such Debenture, if mutilated, the Company will make and deliver a new Debenture of like
tenor. 

Section 5.6. This Debenture shall not entitle the Holder to any of the rights of a 

stockholder of the Company, including without limitation, the right to vote, to receive dividends and other distributions, or to receive any notice of, or to attend, meetings of stockholder or any other proceedings of the Company,
unless and to the extent converted into shares of Common Stock in accordance with the terms hereof. 

Section 5.7. Severability. In case any provision of this Debenture is held by a court of competent jurisdiction to be excessive in scope or otherwise invalid or unenforceable, such provision shall be adjusted rather than voided,
if possible, so that it is enforceable to the maximum extent possible, and the validity and enforceability of the remaining provisions of this Debenture will not in any way be affected or impaired thereby. 

Section 5.8. Headings. The headings of the sections of this Debenture are inserted for convenience only and do not affect the meaning of such section. 

Section 5.9. Counterparts. This Debenture may be executed in multiple counterparts, each of which shall be an original, but all of which shall be deemed to constitute on instrument. 

IN WITNESS WHEREOF, with the intent to be legally bound hereby, the Company as executed this Debenture as of the date first written above. 

	
Holder:
		 
		
Assured Pharmacy, Inc.
	
	 

		 
		
By:
	
	
By:
		 
		 

		 
	 

		 
		
Name: Haresh Sheth
	
	 

		 
		
Title: Chief Operating Officer
	
	
Name:
		 
		 

	
	 

	
	 

	
	
Tax Identification No:
		 
		 

	

EXHIBIT “1” 

CONVERSION NOTICE 

________________________________________________________________________
 (To be executed by the Holder in order to Convert the Debenture) 

TO: 

The undersigned hereby irrevocably elects to convert US$__________ of
the Principal Amount of the above Debenture into Shares of Common Stock of Assured
Pharmacy, Inc., according to the conditions stated therein, as of the Conversion
Date written below. If shares are to be issued in the name of a person other
than the undersigned, the undersigned will pay all transfer taxes payable with
respect thereto and is delivering herewith such certificates and opinions as
reasonably requested by the Company in accordance therewith. No fee will be charged
to the Holder for any conversion, except for such transfer taxes, if any. 

Conversion Date:___________________________________________

Applicable
  Conversion Price: $0.40 

Signature:___________________________________________

Name:___________________________________________

Address:___________________________________________

  

  ___________________________________________

Tax I.D. or Soc. Sec. No:
  ___________________________________________

Principal Amount to be converted:
  

US$
  ________________________________________

Amount of Debenture unconverted: 

US$
  ________________________________________

Number of shares of Common Stock to
        be issued:
  ________________________EX-10.7(B)

 

Exhibit 10.7(b)

Amendment No. 2 to the

Amended and Restated Trust Agreement

By and Between

Air Products and Chemicals, Inc. as Grantor

and

PNC Bank, N.A. as Trustee

Dated 1 August 1999

Covering Defined Benefit Plans

(“Trust Agreement”)

     This Amendment No.2 to the Trust Agreement is made and entered into as of the 11th
day of April 2007 by and between Air Products and Chemicals, Inc. (the “Company”) and PNC Bank,
N.A. (the “Trustee”).

     WHEREAS, the Company and the Trustee have entered into the Trust Agreement, and the Company
wishes to amend and update the Trust Agreement; and

     WHEREAS, Section 6.02(a) of the Trust Agreement provides that the Trust Agreement may be
amended by the Company and the Trustee with the written consent of the Participant Representatives;

     NOW, THEREFORE, in consideration of the mutual agreements contained herein and for other good
and valuable consideration, the parties hereto, intending to be legally bound, agree as follows:

	 	1.	 	Section 2.01 of the Agreement is renamed “Use of Trust Fund and Benefit
Calculation Data” and Section 2.01(b) is amended effective 30 September 2006 to read
as follows:

	 	(b)	 	Benefit Calculation Data
	 
	 	 	 	The Company shall provide to the Trustee the annual fiscal year end valuation
data provided to the Plan’s enrolled actuary for purposes of calculating the
Company’s obligations under the Plan for financial reporting purposes (“Benefit
Calculation Data”). Such data shall be provided no later than 31 December
following the fiscal year end; provided that such data for the Company’s
30 September 2006 fiscal year end will be provided no later than 30 April 2007.
Notwithstanding the foregoing, following a Change in Control, no further updates
or revisions to the Benefit Calculation Data shall be permitted without the
consent of the Participant Representatives. If the Company should fail to
provide

 

 

	 	 	 	to the Trustee the Benefit Calculation Data required hereunder, the Participant
Representatives may provide it.

	 	2.	 	Section 2.02(a)(ii) is amended to read as follows:

	 	(ii)	 	a written certification by the Trust Actuary, based upon the
Benefit Calculation Data and Plan documentation most recently provided to the
Trustee under Sections 2.01(b) and 7.09, respectively, of the amount of and time
at which such payment or payments were due and that the Trust Amount is
sufficient (or the extent to which it is insufficient) to make such payment or
payments without adjustment under Section 2.04.

	 	3.	 	Section 2.02(b) is amended to read as follows:

	 	(b)	 	On and After a Change in Control. Following a Change in Control
and the delivery to the Trustee of a written notice from the Participant
Representatives of the Company’s failure to make a benefit payment or payments
owing to a Participant under the Plan after the Participant’s written request for
such payment to the Plan Administrator, the Trustee shall, within ten days after
the receipt thereof by the Trustee,

	 	(i)	 	provide a copy of such notice to the Participant, the
Company, and the Trust Actuary, and
	 
	 	(ii)	 	direct the Trust Actuary to verify and calculate the
Plan benefit to which the Participant is entitled as soon as possible,
based upon the Benefit Calculation Data and Plan documentation most
recently provided to the Trustee under Sections 2.01(b) and 7.09,
respectively.

	 	 	 	The Trustee shall thereafter pay such benefit to the Participant in the form,
amount or amounts, and at the time or times specified by the Trust Actuary in
writing to the Trustee, to the extent not paid by the Company from its general
funds and subject to adjustment as provided in Section 2.04 at the time said
payment or payments are due.
	 
	 	 	 	In addition, upon a Determination of Taxability, the Trustee shall pay to the
Participants all of the assets comprising the Trust Fund in proportion to the
amounts previously included or which will be required to be included in each
respective Participant’s gross income for federal income tax purposes with
respect to the Trust

2

 

Fund as specified in writing by the Trust Actuary, whereupon the Trust shall be
terminated.

	 	4.	 	Section 5.01 of the Agreement is amended to read as follows:
	 
	 	 	 	“Change in Control” or “Change in Control of the Company” shall mean the first to
occur of any one of the events described below:

	 	(a)	 	Stock Acquisition. Any “person”, as such term is used in
Sections 13(d) and 14(d)(2) of the Securities Exchange Act of 1934 (the “Act”),
other than the Company or a corporation whose outstanding stock entitled to vote
is owned in the majority, directly or indirectly, by the Company, or a trustee of
an employee benefit plan sponsored solely by the Company and/or such a
corporation, is or becomes, other than by purchase from the Company or such a
corporation, the “beneficial owner” (as such term is defined in Rule 13d-3 under
the Act), directly or indirectly, of securities of the Company representing 30%
or more of the combined voting power of the Company’s then outstanding voting
securities. Such a Change in Control shall be deemed to have occurred on the
first to occur of the date securities are first purchased by a tender or exchange
offeror, the date on which the Company first learns of acquisition of 30% of such
securities, or the later of the effective date of an agreement for the merger,
consolidation, or other reorganization of the Company, or the date of approval
thereof by a majority of the Company’s shareholders, as the case may be.
	 
	 	(b)	 	Change in Board. During any 12-month period, individuals who at
the beginning of such period were members of the Board cease for any reason to
constitute at least a majority of the Board, unless the election or nomination
for election by the Company’s shareholders of each new director was approved by a
vote of at least two-thirds of the directors then still in office who were
directors at the beginning of the period. Such a Change in Control shall be
deemed to have occurred on the date upon which the requisite majority of
directors fail to be elected by the shareholders of the Company.
	 
	 	(c)	 	Internal Revenue Code Section 409A. This Section 5.01 shall be
interpreted to comply with the requirements of Internal Revenue Code
Section 409A, as amended.

	 	 	 	The Board of Directors and the chief executive officer of the Company
shall each have the duty to inform the Trustee of a Change in Control or of any
event or events which they believe might occur which would constitute a Change in
Control.

3

 

	 	 	 	A Change in Control shall be deemed to have occurred for purposes of
this Trust Agreement when the Trustee has actual knowledge from a reliable source
of such Change in Control. For this purpose, notice from the Company or
Participant Representatives or a report filed with the Securities and Exchange
Commission, a public statement issued by the Company, or a periodical of general
circulation, including but not limited to The New York Times or the Wall Street
Journal, shall be deemed to be a reliable source upon which the Trustee may rely.
The Trustee has no affirmative obligation or duty to inquire about, investigate,
or consult the foregoing sources for purposes of determining whether a Change in
Control has occurred.

	 	5.	 	Section 5.09 of the Agreement shall be amended to:
	 
	 	 	 	Change “140%” to “110%”.
	 
	 	6.	 	Section 5.10 of the Agreement shall be omitted.
	 
	 	7.	 	Section 5.12 of the Agreement shall be amended to read as follows:
	 
	 	 	 	“Savings Plan” shall mean the Air Products and Chemicals, Inc. Retirement Savings Plan
or, if such plan ceases to exist, any other broad-based employee benefit plan of
the Company as designated by the Company.

     IN WITNESS WHEREOF, the parties have executed this Amendment No. 2 to the Trust Agreement as
of the date set forth above.

	 	 	 	 	 
	 	 	AIR PRODUCTS AND CHEMICALS, INC.
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 	 	PNC BANK, N.A.
	 
	 	 	 	 
	 

	 	By:	 	 
	 

	 	 	 	 
	 
	 	 	 	 
	 

	 	Title:	 	 
	 

	 	 	 	 

4

 

     The undersigned Participant Representatives have signed below in evidence of their consent to
the foregoing amendments.

	 	 	 
	 
	 
	 	 
	W. Douglas Brown
	 	Paul E. Huck
	 	 	 
	 
	 	 
	John P. Jones III
	 	Lynn C. Minella

	 	 	 	 	 
	Attest:
	 	 	 	 
	 

	 	 

	 	 

5

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00133-of-00352.parquet"}]]